Evidence map›Paper›PMID 34430186›Full record

ArticleCureus2021

Evolution of Mortality by Age Group in Patients With COVID-19 Above 60 Years of Age.

Maria Regina Pereira de Godoy, Maria Lucia Machaso Salomão, Flavia Queiroz, Nathalia Furquim Siqueira, Laura Fernandez Cardoso, Andrea Campos Indaló Saurin

Abstract read
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Regina Pereira de GodoyClinica Medica, Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto, BRA.
Maria Lucia Machaso SalomãoEpidemiologia e Saúde Coletiva, Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto, BRA.
Flavia QueirozEpidemiologia e Saúde Coletiva, Hospital de Base, Faculdade de Medicina de São José do Rio Preto (FAMERP), Sao Jose do Rio Preto, BRA.
Nathalia Furquim SiqueiraServiço de Geriatria, Hospital de Base, Fundação Faculdade Regional de Medicina de São José do Rio Preto (FUNFARME), Sao Jose do Rio Preto, BRA.
Laura Fernandez CardosoServiço de Geriatria, Hospital de Base, Fundação Faculdade Regional de Medicina de São José do Rio Preto (FUNFARME), Sao Jose do Rio Preto, BRA.
Andrea Campos Indaló SaurinServiço de Geriatria, Hospital de Base, Fundação Faculdade Regional de Medicina de São José do Rio Preto (FUNFARME), Sao Jose do Rio Preto, BRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction The severity of the diseases associated with the coronavirus worsen the results, increasing the mortality of these patients. Objective The aim of the present study is to report coronavirus disease 2019 (COVID-19) hospitalizations and mortality in 2,359 patients aged over 60 years in a reference center in Brazil. Method The evolution of hospitalizations and overall mortality of patients admitted to Hospital de Base were evaluated in a clinical trial, then selecting patients aged over 60 years, by age group every 10 years, from March 2020 to April 2021, and analyzing whether there was an increase in mortality in age groups, assessed by Fisher's exact test. Results There was an increase in mortality over the decades in this period, but a reduction in hospitalizations after patient vaccination. Conclusion Mortality in patients over 60 years of age is higher than in younger patients, where the vaccine has reduced their hospitalization, but individual patient protection regarding mortality needs further evaluation.

Indexed as

covid-19hospitalizationmortalityoldpeople

Identifiers

PMID34430186
PMCPMC8376142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.